Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Rivo Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Rivo Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 111 · Grade C

Rivo Health

Visit Rivo Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 74 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Rivo Health a bad call — it's best for readers comparing annual-plan offers who can obtain a complete payment schedule and written service terms before enrolling. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
73
Transparency
90
88
Access Breadth
93
96
Clinical Oversight
92
83
Track Record
88
63
CoreAge RxBrief Score 94 · 74Rivo Health

Price, coverage & the tracker

CoreAge RxRivo Health
Brief Score94/100 (A)74/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm annual-plan total

Semaglutide advertised from $149/mo on an annual plan; full commitment, payment schedule and renewal unknown.

Full price details

Compounded semaglutide offered; current annual-plan payment schedule and complete quote unknown; earlier listing: From $149/mo (compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm annual-plan total

Tirzepatide advertised from $199/mo on an annual plan; full commitment, payment schedule and renewal unknown.

Full price details

Compounded tirzepatide offered; current annual-plan payment schedule and complete quote unknown; earlier listing: From $199/mo (compounded)

CoverageUS only; restrictions by state, confirmed at intakeState-specific clinical and pharmacy access requires confirmation; no current state roster established from the reviewed sources
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Rivo Health: The $149 semaglutide and $199 tirzepatide starting rates are marked as annual-plan offers. Full upfront charges, installments and renewal rates remain unknown.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.